•
Sep 30, 2019

Novocure Q3 2019 Earnings Report

Total Revenue
$92.1M
Previous year: $64.8M
+42.2%
EPS
$0.02
Previous year: -$0.13
-115.4%
Active Patients
2.75K
Prescriptions Received
1.32K
Gross Profit
$69.2M
Previous year: $45.8M
+51.0%
Cash and Equivalents
$208M
Previous year: $123M
+69.2%
Free Cash Flow
$9.23M
Previous year: $4.29M
+115.4%
Total Assets
$444M
Previous year: $316M
+40.7%

Novocure

Novocure